1. Home
  2. INSG vs CCCC Comparison

INSG vs CCCC Comparison

Compare INSG & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSG
  • CCCC
  • Stock Information
  • Founded
  • INSG 1996
  • CCCC 2015
  • Country
  • INSG United States
  • CCCC United States
  • Employees
  • INSG N/A
  • CCCC N/A
  • Industry
  • INSG Telecommunications Equipment
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • INSG Telecommunications
  • CCCC Health Care
  • Exchange
  • INSG Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • INSG 110.6M
  • CCCC 104.4M
  • IPO Year
  • INSG 2000
  • CCCC 2020
  • Fundamental
  • Price
  • INSG $7.67
  • CCCC $2.38
  • Analyst Decision
  • INSG Buy
  • CCCC Buy
  • Analyst Count
  • INSG 3
  • CCCC 3
  • Target Price
  • INSG $13.00
  • CCCC $12.00
  • AVG Volume (30 Days)
  • INSG 226.7K
  • CCCC 1.7M
  • Earning Date
  • INSG 08-06-2025
  • CCCC 07-31-2025
  • Dividend Yield
  • INSG N/A
  • CCCC N/A
  • EPS Growth
  • INSG N/A
  • CCCC N/A
  • EPS
  • INSG 0.31
  • CCCC N/A
  • Revenue
  • INSG $185,412,000.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • INSG N/A
  • CCCC N/A
  • Revenue Next Year
  • INSG $14.39
  • CCCC N/A
  • P/E Ratio
  • INSG $24.70
  • CCCC N/A
  • Revenue Growth
  • INSG 20.40
  • CCCC 98.56
  • 52 Week Low
  • INSG $6.24
  • CCCC $1.09
  • 52 Week High
  • INSG $20.67
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • INSG 43.20
  • CCCC 76.86
  • Support Level
  • INSG $8.06
  • CCCC $1.36
  • Resistance Level
  • INSG $9.07
  • CCCC $2.41
  • Average True Range (ATR)
  • INSG 0.44
  • CCCC 0.19
  • MACD
  • INSG -0.06
  • CCCC 0.09
  • Stochastic Oscillator
  • INSG 3.45
  • CCCC 97.04

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: